NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Eric T Sugarman
Philadelphia College of Osteopathic Medicine - Philadelphia / United States
Medical and Health Sciences / Ophthalmology
AD Scientific Index ID: 4772803
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Eric T Sugarman's MOST POPULAR ARTICLES
1-)
In perspective: An update on telomere targeting in cancer ET Sugarman, G Zhang, JW Shay Molecular carcinogenesis 58 (9), 1581-1588, 2019 402019
2-)
Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanomaB Wang, W Zhang, G Zhang, L Kwong, H Lu, J Tan, N Sadek, M Xiao, ...Oncogene 40 (37), 5590-5599, 2021342021
3-)
Induction of telomere dysfunction prolongs disease control of therapy-resistant melanomaG Zhang, LW Wu, I Mender, M Barzily-Rokni, MR Hammond, O Ope, ...Clinical Cancer Research 24 (19), 4771-4784, 2018332018
4-)
Targeting HSP90 as a novel therapy for cancer: mechanistic insights and translational relevanceJ Zhang, H Li, Y Liu, K Zhao, S Wei, ET Sugarman, L Liu, G ZhangCells 11 (18), 2778, 2022332022
5-)
Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanomaK Du, S Wei, Z Wei, DT Frederick, B Miao, T Moll, T Tian, E Sugarman, ...Nature communications 12 (1), 6023, 2021312021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept